Eye Diseases

Eye Diseases

Elevate Your Eye Disease Drug Development with AniLocus In Vivo Preclinical CRO Services

Our team comprehends the intricacies and time-sensitive nature of drug development for eye diseases, encompassing congenital disorders to age-related conditions.

At AniLocus, we pride ourselves on delivering a holistic approach to IND-enabling preclinical studies, meticulously designed to validate the efficacy and safety of groundbreaking therapies. As a dynamic and growing Contract Research Organization (CRO), our mission is clear: to make a tangible impact on the lives of millions grappling with debilitating eye conditions.

Look deeper into our preclinical CRO services for eye diseases, meticulously curated to support your scientific endeavors, while upholding the highest standards of quality and safety. Explore our expansive array of translational animal models catered to your research needs, including:

  • Age-Related Macular Degeneration (AMD): Unearth novel insights into the treatment of this prevalent age-related eye disease.
  • Blepharitis: Investigate potential interventions for this chronic eyelid inflammation disorder.
  • Cataract: Unlock innovative solutions for cataract prevention and treatment.
  • Diabetic Retinopathy: Address the pressing need for advanced therapies for diabetes-related retinal damage.
  • Glaucoma: Advance your understanding of glaucoma pathogenesis and therapeutic strategies.
  • Glaucomatous Optic Neuropathy: Explore models for studying optic nerve damage in glaucoma.
  • Intraocular Pressure Drugs (IOP): Investigate new avenues for managing intraocular pressure.
  • Ocular Inflammation (Dry Eye Disease, Ocular Allergy): Enhance your knowledge of ocular inflammation and its management.
  • Ocular Pain: Discover innovative approaches to alleviate ocular discomfort.
  • Ocular Surface Diseases: Gain insights into the treatment of various ocular surface conditions.
  • Optic Nerve Injury Models: Investigate optic nerve injuries and potential therapeutic interventions.
  • Photoreceptor Degeneration: Study photoreceptor loss and potential restoration strategies.
  • Presbyopia: Explore novel treatments for age-related visual impairment.
  • Retinal Diseases: Contribute to the advancement of therapies for diverse retinal disorders.

Partner with AniLocus, where your research aspirations align with our commitment to excellence. Together, let’s accelerate the drug development process and pioneer transformative treatments for eye diseases, making a profound impact on global eye health.

We stand for quality, safety & credibility. Our goal at Anilocus is to support you in the drug development process.

Ask us about our CRO services for ophthalmic drug development:

    Primary Contact/Sponsor


    Full Name*:


    Position Title*:



    Sponsor Organization/Institution*:

    Sponsor Website:

    Project Details

    Type of Study*:

    Other (Specify):

    Drug Development Phase*:

    Specific Objectives/Outcomes*:

    Study Requirements

    Animal Model*:

    Other (Specify):

    Number of Groups*:

    Sample Size (Per Group)*:

    Study Duration/Timeline*:

    Budget Constraints (if any) *:

    Additional Information

    Any Specific Assays or Tests Required*:

    Regulatory Requirements*:

    Terms and Conditions

    Terms of Service and Agreement*:

    Experimental Equipment for Eye Disease Model Validation & Therapy Evaluation

    The choice of equipment may vary depending on the specific research goals and our team can help you determine which equipment is most applicable to your study. It depends on the type of eye disease being studied. Review the list below to learn more about how we can validate eye disease models and ocular and retinal therapies:

    Ophthalmic Imaging and Diagnostics:

    • Optical Coherence Tomography (OCT) machines
    • Fundus cameras
    • Scanning laser ophthalmoscopes (SLO)
    • Slit-lamp biomicroscopes

    Electroretinography (ERG) Equipment:

    • ERG recording systems
    • Electrode assemblies (e.g., corneal electrodes, skin electrodes)
    • Amplifiers and signal processing units

    Intraocular Pressure (IOP) Measurement:

    • Tonometers (e.g., applanation tonometers, rebound tonometers)
    • IOP telemetry systems
    • Manometers for measuring aqueous humor pressure

    Drug Delivery and Dosing Systems:

    • Micropipettes and microinjectors for intraocular injections
    • Controlled-release drug delivery implants
    • Ocular inserts and patches
    • Microsyringe pumps

    Behavioral and Functional Testing:

    • Vision testing apparatus (e.g., Morris Water Maze for spatial navigation studies)
    • Operant conditioning chambers for studying visual perception
    • Gait analysis systems for assessing mobility

    Microscopy and Histology:

    • Electron microscopes (TEM and SEM) for ultrastructural analysis
    • Light microscopes with various contrast techniques
    • Cryostats and microtomes for tissue sectioning
    • Immunohistochemistry and immunofluorescence equipment

    Surgical and Microsurgical Instruments:

    • Ophthalmic surgical microscopes
    • Fine microsurgical instruments (e.g., microforceps, microscissors)
    • Suturing and suturing aids

    Frequently asked questions about in vivo research for eye disease therapies:

    In vivo research refers to experiments or studies conducted within a living organism, often animals, to better understand biological processes and test potential therapies. It’s crucial for eye disease therapies because it allows researchers to study the disease in a complex, living system, providing insights that cannot be obtained through cell culture or computer modeling alone. Connect with our team to learn how in vivo research helps bridge the gap between basic science and clinical applications.

    In vivo research for eye diseases often involves rodents like mice and rats, as well as larger animals like rabbits and non-human primates. The choice of animal model depends on the specific research objectives, regulatory requirements, and the similarities of the animal’s eye anatomy and physiology to humans.

    Our CRO can induce eye diseases in animal models through various methods, such as genetic modification, chemical exposure, or surgical procedures. Ethical guidelines and regulations are in place to ensure the humane treatment of animals in research. These guidelines include proper housing, pain management, and efforts to minimize animal suffering. Ethical considerations are integral to the planning and conduct of in vivo studies. Ask us about IACUC protocol development.

    AniLocus Eye Disease CRO specializes in in vivo research for drug discovery and drug development providing a wide range of services. This includes the development and validation of animal models specific to eye diseases, efficacy and safety testing of drug candidates, pharmacokinetics studies, toxicology assessments, and regulatory support. Check out all of our study services.

    Yes, we have experience in regulatory affairs and can assist in preparing and submitting documentation to regulatory authorities. We can help ensure that your eye disease drug development project complies with relevant guidelines and standards.

    Outsourcing to our CRO can offer several advantages, including access to specialized expertise, state-of-the-art equipment, and validated animal models. It can also save time and resources compared to setting up in-house capabilities. We can provide a more cost-effective and efficient way to conduct preclinical studies.

    Yes, AniLocus CRO offers customizable services to tailor their research to your specific needs. Whether you require a particular animal model, a unique study design, or specific endpoints, we can often accommodate these requirements to ensure the relevance and success of your eye disease drug development project.

    The timeline for in vivo research can vary depending on the complexity of the project, the specific studies involved, and regulatory requirements. We work closely with clients to establish realistic timelines, but it’s important to plan well in advance, as certain studies may take several months to complete.

    To get started, reach out to our team! We specialize in eye disease research and discuss the details of your project, including your specific research goals, timelines, and budget constraints. We offer an initial consultation to discuss your needs and develop a tailored research plan to meet your objectives. Let’s get started today!

    Effective communication and transparent reporting are essential for a successful partnership with us. We provide regular updates on study progress, results, and any potential issues through the AniLocus Client Portal. Clear lines of communication and a collaborative approach are key to achieving your eye disease drug development goals.

    Effective communication and transparent reporting are essential for a successful partnership with us. We provide regular updates on study progress, results, and any potential issues through the AniLocus Client Portal. Clear lines of communication and a collaborative approach are key to achieving your eye disease drug development goals.